Gross profit increased 23.2%
Gross profit changed +23.2% from the comparable as-filed period.
$49.0M→$60.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AGYS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 304 bp lower
Free-cash-flow margin changed -304 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.91%→15.87%2 prior comparisons
Working capital / assets moved 1502 bp higher
Working capital / assets changed +1502 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
4.98%→20.00%4 prior comparisons
Stock-based compensation increased 25.9%
Stock-based compensation changed +25.9% from the comparable as-filed period.
$5.0M→$6.3M2 prior comparisons
Trade receivables increased 11.7%
Trade receivables changed +11.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$36.8M→$41.1M4 prior comparisons
Operating income increased 7.8%
Operating income changed +7.8% from the comparable as-filed period.
$14.1M→$15.2M2 prior comparisons
Total assets increased 16.4%
Total assets changed +16.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$425.6M→$495.5M4 prior comparisons
Net income increased 12.5%
Net income changed +12.5% from the comparable as-filed period.
$11.7M→$13.2M2 prior comparisons
Free-cash-flow proxy decreased 1.2%
Free-cash-flow proxy changed -1.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$15.0M→$14.8M3 prior comparisons
Current liabilities increased 12.0%
Current liabilities changed +12.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$96.7M→$108.4M4 prior comparisons
Operating cash-flow margin moved 293 bp lower
Operating cash-flow margin changed -293 basis points from the comparable as-filed period.
19.18%→16.25%2 prior comparisons
Operating cash flow decreased 0.3%
Operating cash flow changed -0.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$15.2M→$15.2M3 prior comparisons
Research & development increased 11.3%
Research & development changed +11.3% from the comparable as-filed period.
$17.8M→$19.8M2 prior comparisons
Inventory / revenue moved 146 bp higher
Inventory / revenue changed +146 basis points from the comparable as-filed period.
9.73%→11.19%2 prior comparisons
Receivables / revenue moved 237 bp lower
Receivables / revenue changed -237 basis points from the comparable as-filed period.
46.40%→44.03%2 prior comparisons
Capex / revenue moved 11 bp higher
Capex / revenue changed +11 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.27%→0.38%2 prior comparisons
Cost of revenue increased 9.0%
Cost of revenue changed +9.0% from the comparable as-filed period.
$30.3M→$33.1M2 prior comparisons
SBC / revenue moved 44 bp higher
SBC / revenue changed +44 basis points from the comparable as-filed period.
6.31%→6.74%2 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
28,042,508→28,215,8058 prior comparisons
Operating cash flow / net income decreased 11.4%
Operating cash flow / net income changed -11.4% from the comparable as-filed period.
1.3→1.152 prior comparisons
R&D / revenue moved 122 bp lower
R&D / revenue changed -122 basis points from the comparable as-filed period.
22.48%→21.26%2 prior comparisons
Revenue increased 14.3%
Revenue changed +14.3% from the comparable as-filed period.
$76.7M→$87.7M2 prior comparisons
Stockholders' equity increased 19.5%
Stockholders' equity changed +19.5% from the comparable as-filed period.
$283.2M→$338.3M2 prior comparisons
Free-cash-flow margin moved 1483 bp higher
Free-cash-flow margin changed +1483 basis points from the comparable as-filed period.
-6.49%→8.34%2 prior comparisons
Operating cash-flow margin moved 1460 bp higher
Operating cash-flow margin changed +1460 basis points from the comparable as-filed period.
-5.67%→8.93%2 prior comparisons
Current ratio increased 56.5%
Current ratio changed +56.5% from the comparable as-filed period.
1.11→1.743 prior comparisons
Working capital / assets moved 1384 bp higher
Working capital / assets changed +1384 basis points from the comparable as-filed period.
2.58%→16.41%3 prior comparisons
Research & development increased 16.0%
Research & development changed +16.0% from the comparable as-filed period.
$17.5M→$20.2M2 prior comparisons
Gross profit increased 17.7%
Gross profit changed +17.7% from the comparable as-filed period.
$47.3M→$55.7M2 prior comparisons
Receivables / revenue moved 392 bp lower
Receivables / revenue changed -392 basis points from the comparable as-filed period.
45.72%→41.80%2 prior comparisons
Inventory increased 19.7%
Inventory changed +19.7% from the comparable as-filed period.
$6.6M→$7.9M3 prior comparisons
Stock-based compensation increased 19.1%
Stock-based compensation changed +19.1% from the comparable as-filed period.
$5.0M→$6.0M2 prior comparisons
Total assets increased 11.0%
Total assets changed +11.0% from the comparable as-filed period.
$426.0M→$472.8M3 prior comparisons
Capital expenditure decreased 17.9%
Capital expenditure changed -17.9% from the comparable as-filed period.
$633,000→$520,0002 prior comparisons
Current liabilities increased 7.4%
Current liabilities changed +7.4% from the comparable as-filed period.
$97.6M→$104.8M3 prior comparisons
Capex / revenue moved 23 bp lower
Capex / revenue changed -23 basis points from the comparable as-filed period.
0.83%→0.59%2 prior comparisons
Cost of revenue increased 9.0%
Cost of revenue changed +9.0% from the comparable as-filed period.
$29.4M→$32.0M2 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
28,042,795→28,205,7888 prior comparisons
SBC / revenue moved 27 bp higher
SBC / revenue changed +27 basis points from the comparable as-filed period.
6.56%→6.83%2 prior comparisons
Inventory / revenue moved 41 bp higher
Inventory / revenue changed +41 basis points from the comparable as-filed period.
8.64%→9.04%2 prior comparisons
Trade receivables increased 4.5%
Trade receivables changed +4.5% from the comparable as-filed period.
$35.1M→$36.6M3 prior comparisons
Operating cash flow / net income changed across a sign change
Operating cash flow / net income changed +198.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-0.89→0.872 prior comparisons
R&D / revenue moved 33 bp higher
R&D / revenue changed +33 basis points from the comparable as-filed period.
22.76%→23.09%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.